首页> 外国专利> CASP POLYMORPHISM AS A PROGNOSTIC MARKER FOR LUNG CANCER AND METHOD FOR PREDICTING THE SURVIVALS AND THE RISK OF DEVELOPING LUNG CANCER USING THEM

CASP POLYMORPHISM AS A PROGNOSTIC MARKER FOR LUNG CANCER AND METHOD FOR PREDICTING THE SURVIVALS AND THE RISK OF DEVELOPING LUNG CANCER USING THEM

机译:CASP多态性作为肺癌的预后标志物,以及预测肺癌生存率和发展肺癌的方法

摘要

PURPOSE: A marker for predicting risk and prognosis of lung cancer using SNP of CASP7 and/or CASP9 gene is provided to predict lung cancer occurrence possibility and to enhance survival rate of a patient with lung cancer. CONSTITUTION: A marker for predicting risk and prognosis of lung cancer contains comprises: a polynucleotide with 10 or more DNA sequences having 1151th base which is C or G in CASP7 gene of sequence number 1; a polynucleotide with 10 or more DNA sequences having 637th base which is C or T in CASP9 gene of sequence number 2; or complementary polynucleotide thereof. A composition for predicting risk and prognosis of lung cancer contains an agent which is able to measure mRNA or protein level of CASP7 or CASP9 gene.
机译:目的:提供一种使用CASP7和/或CASP9基因的SNP预测肺癌危险性和预后的标志物,以预测肺癌发生的可能性并提高肺癌患者的生存率。组成:预测肺癌的风险和预后的标志物包括:具有10个或更多具有1151个碱基的DNA序列的多核苷酸,该碱基在序列号1的CASP7基因中为C或G;和具有10个或10个以上具有637个碱基的DNA序列的多核苷酸,其在序列号2的CASP9基因中为C或T;或其互补的多核苷酸。用于预测肺癌风险和预后的组合物包含能够测量CASP7或CASP9基因的mRNA或蛋白质水平的试剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号